Effects of rimegepant 75  mg daily on the pharmacokinetics of a combined oral contraceptive containing ethinyl estradiol and norgestimate in healthy female participants

CONCLUSIONS: The study identified modest elevations in overall EE and NGMN exposures after multiple doses of rimegepant, but these elevations are unlikely to be clinically relevant in healthy females with migraine.PMID:37140071 | DOI:10.1111/head.14512

Source: Headache - May 4, 2023 Category: Neurology Authors: Rajinder Bhardwaj Joseph C Stringfellow Beth Morris Robert S Croop Richard J Bertz Source Type: research